The effect of Sertraline, Paroxetine, Fluoxetine and Escitalopram on testicular tissue and oxidative stress parameters in rats

International Braz J Urol

Volumn 40, Issue 1, 2014, Pages 100-108

  Erdemir, Fikret ^a   Atilgan, Dogan ^a   Firat, Fatih ^a   Markoc, Fatma ^a   Parlaktas, Bekir Suha ^a   Sogut, Erkan ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

etiology Subheading ; Infertility; Male; Spermatozoa

Indexed keywords

CITALOPRAM; FLUOXETINE; FOLLITROPIN; LUTEINIZING HORMONE; MALONALDEHYDE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TESTOSTERONE;

ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; EVALUATION STUDY; MALE; OXIDATIVE STRESS; RANDOMIZATION; RAT; SPERMATOGENESIS; TESTIS; WISTAR RAT;

ANIMALS; CITALOPRAM; FLUOXETINE; FOLLICLE STIMULATING HORMONE; LUTEINIZING HORMONE; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PAROXETINE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SPERMATOGENESIS; TESTIS; TESTOSTERONE;

EID: 84897863125     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-5538.IBJU.2014.01.15     Document Type: Article

References (38)

1. Jungwirth A, Diemer T, Dohle GR, Giwercman A, Kopa Z, Tournaye H. EAU guidelines on male infertility. Eur Urol. 2013:7.
2. Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA: National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012; 9:e1001356.
3. Sofikitis N, Giotitsas N, Tsounapi P, Baltogiannis D, Giannakis D, Pardalidis N. Hormonal regulation of spermatogenesis and spermiogenesis. J Steroid Biochem Mol Biol. 2008; 109 :323-30.
4. Dohle GR, Colpi GM, Hargreave TB, Papp GK, Jungwirth A, Weidner W; et al.: EAU guidelines on male infertility. Eur Urol. 2005; 48: 703-11.
5. Cabler S, Agarwal A, Flint M, du Plessis SS: Obesity: modern man's fertility nemesis. Asian J Androl. 2010; 12: 480-9.
6. Hougaard KS, Hannerz H, Feveile H, Bonde JP: Increased incidence of infertility treatment among women working in the plastics industry. Reprod Toxicol. 2009; 27: 186-9.
7. Rendtorff R, Hohmann C, Reinmuth S, Müller A, Dittrich R, Beyer M, et al.: Hormone and Sperm Analyses after Chemoand Radiotherapy in Childhood and Adolescence. Klin Padiatr. 2010; 222: 145-9.
8. Dohle GR: Male infertility in cancer patients: Review of the literature. Int J Urol. 2010; 17: 327-31.
9. Sheehan DV, Mao CG: Paroxetine treatment of generalized anxiety disorder. Psychopharmacol Bull. 2003; 37 (Suppl) 1:64-75.
10. Carrasco JL, Sandner C: Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview. Int J Clin Pract. 2005; 59: 1428-34.
11. Pirraglia PA, Stafford RS, Singer DE: Trends in Prescribing of Selective Serotonin Reuptake Inhibitors and Other Newer Antidepressant Agents in Adult PrimaryCare. Prim Care Companion J Clin Psychiatry. 2003; 5: 153-7.
12. Hellstrom WJ: Update on treatments for premature ejaculation. Int J Clin Pract. 2011; 65: 16-26.
13. Brambilla P, Cipriani A, Hotopf M, Barbui C: Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis ofclinical trial data. Pharmacopsychiatry. 2005; 38: 69-77.
14. Bilge S, Bozkurt A, Bas DB, Aksoz E, Savli E, Ilkaya F, Kesim Y: Chronic treatment with fluoxetine and sertraline prevents forced swimming test-induced hypercontractility of rat detrusormuscle. Pharmacol Rep. 2008; 60: 872-9.
15. Snoeren EM, Refsgaard LK, Waldinger MD, Olivier B, Oosting RS: Chronic paroxetine treatment does not affect sexual behavior in hormonally sub-primed female rats despite 5-HT-(A) receptor desensitization. J Sex Med. 2011; 8: 976-88.
16. Hui J, Zhang Z, Liu S, Xi G, Zhang X, Teng G, et al.: Adolescent escitalopram administration modifies neurochemical alterations in the hippocampus of maternally separated rats. Eur Neuropsychopharmacol. 2010; 20: 875-83.
17. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990; 186: 407-21.
18. Hay DW, Wadsworth RM: The contractile effects of 5-hydroxytryptamine on the rat isolated vas deferens.Br J Pharmacol. 1982; 77: 605-13.
19. Collin O, Damber JE, Bergh A: 5-Hydroxytryptamine--a local regulator of testicular blood flow and vasomotion in rats. J Reprod Fertil. 1996; 106: 17-22.
20. Jiménez-Trejo F, Tapia-Rodríguez M, Queiroz DB, Padilla P, Avellar MC, Manzano PR, et al.: Serotonin concentration, synthesis, cell origin, and targets in the rat caput epididymis during sexual maturation andvariations associated with adult mating status: morphological and biochemical studies. J Androl. 2007; 28: 136-49.
21. Syed V, Gomez E, Hecht NB: Messenger ribonucleic acids encoding a serotonin receptor and a novel gene are induced in Sertoli cells by a secretedfactor(s) from male rat meiotic germ cells. Endocrinology. 1999; 140: 5754-60.
22. Fujinoki M: Serotonin-enhanced hyperactivation of hamster sperm. Reproduction. 2011; 142: 255-66.
23. Gonzales GF, Garcia-Hjarles M, Velasquez G: Hyperprolactinaemia and hyperserotoninaemia: their relationship to seminal quality. Andrologia. 1992; 24: 95- 100.
24. Parisi E, De Prisco P, Capasso A, del Prete M: Serotonin and sperm motility. Cell Biol Int Rep. 1984; 8: 95.
25. Simpson GM, Blair JH, Iqbal J, Iqbal F: A preliminary study of trimiprimine in chronic schizophrenia. Curr Ther Res Clin Exp. 1966; 8: 225-31.
26. Kurland AA, Pinto A, Destounis N, Babikow PW: Effects of trimeprimine (surmontil) on spermatogenesis and mood in normal volunteers. Curr Ther Res Clin Exp. 1970; 12: 186-91.
27. Ortiz á, Espino J, Bejarano I, Lozano GM, Monllor F, García JF, et al.: The correlation between urinary 5-hydroxyindoleacetic acid and sperm quality in infertile men and rotating shift workers. Reprod Biol Endocrinol. 2010 8; 8:138.
28. Tanrikut C, Schlegel PN: Antidepressant-associated changes in semen parameters. Urology. 2007; 69: 185.e5-7.
29. Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, et al.: Disorders of orgasm and ejaculation in men. J Sex Med. 2010; 7: 1668-86.
30. Tanrikut C, Feldman AS, Altemus M, Paduch DA, Schlegel PN: Adverse effect of paroxetine on sperm. Fertil Steril. 20100; 94: 1021-6.
31. Safarinejad MR: Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detectedusing semen analysis and sperm chromatin structure assay. J Urol. 2008; 180: 2124-8.
32. Relwani R, Berger D, Santoro N, Hickmon C, Nihsen M, Zapantis A, et al.: Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery. Reprod Sci. 2011; 18: 391-7.
33. Kumar VS, Sharma VL, Tiwari P, Singh D, Maikhuri JP, Gupta G, et al.: The spermicidal and antitrichomonas activities of SSRI antidepressants. Bioorg Med Chem Lett. 2006; 16: 2509-12.
34. Bataineh HN, Daradka T: Effects of long-term use of fluoxetine on fertility parameters in adult male rats. Neuro Endocrinol Lett. 2007; 28: 321-5.
35. Das TK, Mazumder R, Biswas NM: Effect of intraventricular injection of 5,6-dihydroxytryptamine on spermatogenesis and plasma testosterone levels in the rat. J Endocrinol. 1985; 106: 395-400.
36. Bell S, Shipman M, Bystritsky A, Haifley T: Fluoxetine treatment and testosterone levels. Ann Clin Psychiatry. 2006; 18: 19-22.
37. Tinkel J, Hassanain H, Khouri SJ: Cardiovascular antioxidant therapy: a review of supplements, pharmacotherapies, and mechanisms. Cardiol Rev. 2012; 20: 77-83.
38. Morakinyo AO, Iranloye BO, Daramola AO, Adegoke OA: Antifertility effect of calcium channel blockers on male rats: association with oxidative stress. Adv Med Sci. 2011; 56: 95-105.